Distinguished Cardiologist Takes the Helm at Pioneering Foundation in Interventional Cardiology
New York, NY – September 11, 2017 – The Cardiovascular Research Foundation (CRF) today announced the appointment and promotion of Juan F. Granada, MD, as the foundation’s President and Chief Executive Officer. Dr. Granada was also appointed to CRF’s Board of Directors. A renowned leader in cardiology, he joined CRF in 2007 and served as Executive Director and Chief Innovation Officer at the CRF Skirball Center for Innovation. He is also an Assistant Professor of Medicine at Columbia University College of Physicians and Surgeons.
“Juan’s proven leadership skills, along with his expertise across preclinical, clinical, and educational initiatives will help CRF strengthen and expand its role in the development of innovative new technologies and therapies that will benefit people with heart disease worldwide,” said Eric B. Woldenberg, Esq., Chairman of the CRF Board of Directors and a senior partner at Pryor Cashman LLP.
“Since its inception, CRF has played a major role in the rapid progress that has been made in interventional cardiology by establishing the safe use of new technologies and therapies for heart disease,” said Dr. Granada. “I am eager to take on this new role and work with my distinguished colleagues to ignite the next wave of innovation that will help doctors save and improve the quality of their patients’ lives.”
“CRF has grown due to a special blend of passion, creativity, and productivity, and Juan embodies our innovative culture,” said Martin B. Leon, MD, Founder and Chairman Emeritus of CRF and its Co-Director, Medical Research and Education. “With his unique combination of advanced interventional skills, entrepreneurial spirit, and business insight, he has the visionary capacity to foresee new opportunities. Importantly, Juan is a caring and thoughtful ‘people person’ who will catalyze communication and collaboration both inside and outside the organization.”
“Juan’s professionalism, creativity and ‘can do’ mindset make him an exceptional individual for this position,” added Gregg W. Stone, MD, CRF’s Co-Director of Medical Research and Education. “His knowledge of interventional cardiovascular medicine from bench to bedside coupled with extensive expertise in medical innovation will propel CRF to new levels of achievement in research and education.”
Dr. Granada is one of the world’s foremost investigators in the translational validation of novel cardiovascular therapies. He has helped develop and successfully validate several endovascular imaging and device technologies. He received his medical degree from the Institute of Health Sciences in Medellin, Colombia and finished his cardiovascular disease and interventional cardiology fellowships at Baylor College of Medicine in Houston, Texas.